Adaptimmune Therapeutics and The University of Texas MD Anderson Cancer Center announced today they have entered into a multi-year strategic alliance designed to expedite the development of novel adoptive T-cell therapies for multiple types of cancer.
http://www.newswise.com/articles/md-anderson-cancer-center-and-adaptimmune-form-strategic-alliance-to-advance-development-of-immunotherapies-targeting-multiple-cancers
MD ANDERSON CANCER CENTER AND ADAPTIMMUNE FORM STRATEGIC ALLIANCE TO ADVANCE DEVELOPMENT OF IMMUNOTHERAPIES TARGETING MULTIPLE CANCERS